Lung Scan Technology Reveals Hidden Secrets of Airway Disease
Scientists Unveil 4DMedical Imaging Breakthrough that Spots Early Lung Disease Missed by Standard Tests LOS ANGELES, July 15, 2025 /PRNewswire/ -- Researchers at Vanderbilt University, Johns Hopkins University, University of Miami, and The Alfred Hospital studied the lungs of subjects including Veterans using technology developed by 4DMedical called X-ray Velocimetry Lung Ventilation Analysis Software...
AIRS Medical Unveils Major SwiftMR® Update, Enabling Greater Autonomy in MRI Operations
SEOUL, South Korea, July 15, 2025 /PRNewswire/ -- AIRS Medical, pioneers in AI-powered solutions for diagnostic imaging, today announced a major update1 to SwiftMR, the software that reduces MRI scan times by up to 50%2 while enhancing image quality. The latest release introduces new capabilities designed to give providers more flexibility...
Argon Medical Streamlines Distribution of Product and Enhances Customer Training for Europe, Asia, and Africa with the Debut of a Modern, Mixed-Use Facility
PLANO, Texas, July 15, 2025 /PRNewswire/ -- Argon Medical, a leading provider of medical device solutions for Interventional Radiology, Vascular Surgery, Interventional Cardiology, and Oncology procedures, announces the grand opening of its new Distribution & Education Center (ADEC), strategically located in Derby, United Kingdom. This state-of-the-art facility represents a major step...
Youthful Narrative Bridges Traditional Chinese Medicine to Global Audience
LIAOCHENG, China, July 15, 2025 /PRNewswire/ -- Amidst global challenges in chronic disease prevention and health management, Traditional Chinese Medicine (TCM)'s core principles of "preventive treatment of disease" (zhi wei bing, 治未病) and "harmony between humanity and nature" (tian ren he yi, 天人合一) are gaining international attention. The TCM cultural program The Young TCM Masters, co-produced by Dong-E-E-Jiao Co.,...
AXA and China Biotech Services Sign Memorandum of Understanding
Joint effort to explore innovative cancer treatment solutions and broaden options for customers HONG KONG, July 15, 2025 /PRNewswire/ -- AXA China Region Insurance Company (Bermuda) Limited, together with AXA International Reinsurance (Shanghai) Company Limited ("AXA"), is pleased to announce the signing of a strategic Memorandum of Understanding (MoU) with China Biotech Services Holdings Limited ("China Biotech Services")....
Baraya Extended Care Closes Series B Funding Round Bringing Total Capital Raised to USD 124 Million from TVM Capital Healthcare and a Syndicate of Prominent Investors
TVM Capital Healthcare's oversubscribed fundraise for Baraya Extended Care addresses critical gaps in long-term care, supporting Saudi Arabia's Vision 2030 healthcare goals. DUBAI, UAE and RIYADH, Saudi Arabia, July 15, 2025 /PRNewswire/ -- TVM Capital Healthcare announces the closing of a Series B fundraising, surpassing its target and bringing the total...
Divamics’ AI and Molecular Dynamics Platform Powers Breakthroughs in Metabolic Disease Drug Discovery for Partners
SUZHOU, China, July 15, 2025 /PRNewswire/ -- Divamics, a pioneer in AI-driven drug discovery, highlighted its critical role in advancing metabolic disease therapeutics through its advanced AI and molecular dynamics(MD) platform. This powerful platform recently supported the successful design of BGM1812, a novel dual AMY3R/CTR receptor agonist for obesity treatment, as published in the July 2025 issue...
Ascletis Completes Dosing of All Participants in Its U.S. Clinical Study Combining Adipose-Targeted, Once-Monthly Injectable Small Molecule THRβ Agonist, ASC47, and Semaglutide for the Treatment of Obesity
- The combination study, conducted in the U.S., is designed to evaluate the safety, tolerability and preliminary efficacy at Day 29 of a single-dose of ultra-long-acting subcutaneously administered ASC47 (half-life up to 40 days) in combination with four doses of semaglutide (0.5 mg, once weekly) in 28 participants with obesity. - Initiated in May 2025, all 28 participants were...
Concord Healthcare Announces Completion of China’s First Proton Therapy for Choroidal Malignant Melanoma
BEIJING, July 15, 2025 /PRNewswire/ -- Concord Healthcare Group Co., Ltd. ("Concord Healthcare"), a subsidiary of Concord Medical Services Holdings Limited (the "Company") (NYSE: CCM), which subsidiary is listed on the Main Board of The Stock Exchange of Hong Kong Limited (the "HKSE") under the stock code 2453.HK, announced that on July 11, 2025, Guangzhou Concord Cancer Center, a subsidiary...
LABCONNECT APPOINTS MITCHELL BLUMENFELD AS CHIEF FINANCIAL OFFICER
JOHNSON CITY, Tenn., July 15, 2025 /PRNewswire/ -- LabConnect is pleased to announce the appointment of Mitch Blumenfeld as its Chief Financial Officer, effective August 4, 2025. Mitch joins LabConnect with proven experience as Chief Financial Officer for high-growth companies in multiple industries including pharmaceutical services, wholesale pharmaceutical distribution, and diversified manufacturing...
